Moderna shares pop 7% after Cowen upgrades stock, saying it ‘will be a leader’ in RSV vaccines

Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will "be a leader" in the RSV vaccine market. 



Source link